Caliper Life Sciences announced this week that John DelliSanti will be the company’s new executive vice president and chief commercial officer. In this position, DelliSanti will be in charge of Caliper’s worldwide sales, marketing and services efforts.
Prior to joining Caliper, DelliSanti led commercial operations at Invitrogen and held various positions at the chemical software and informatics company Accelrys.
Biopharmaceutical company Acceleron Pharma announced last week the appointment of Robert Steininger as senior VP of Manufacturing.
Previously, Steininger was VP of process sciences at Millennium Pharmaceuticals, and held multiple positions at Genetics Institute, now Wyeth Pharmaceuticals, from 1984 to 2000.